AbbVie Reports First-Quarter 2024 Financial Results
Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These...
Stay updated with breaking news from Colitis Organisation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These...
Mindfulness-based cognitive therapy decreases psychological distress and improves positive mental health and fatigue in adults with IBD.
An AI-assisted image-enhanced endoscopy system accurately assessed vascular healing and predicted clinical relapse in patients with ulcerative colitis.
Patients with Crohn's disease who are considered high-risk as determined by capsule endoscopy but are in clinical remission benefit from a treat-to-target strategy, a new study shows.
Celltrion today presented positive twoyear results from the extended LIBERTY studies LIBERTYCD1 and LIBERTYUC2 in patients with moderately to severely active Crohns disease CD and ulcerative colitis UC. Celltrion also presented endoscopic outcomes from the posthoc analysis of the LIBERTYCD study.3